We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
-18.67%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$70.1M
AUM Growth
-$25.1M
Cap. Flow
+$1.55M
Cap. Flow %
2.22%
Top 10 Hldgs %
77.51%
Holding
34
New
3
Increased
3
Reduced
8
Closed
6

Top Buys

Rank Stock Value
1
ANIP icon
ANI Pharmaceuticals
ANIP
+$10.8M
2
QLTI
QLT Inc
QLTI
+$183K
3
ZGNX
Zogenix, Inc.
ZGNX
+$10.8K

Top Sells

Rank Stock Value
1
AMRI
Albany Molecular Research Inc
AMRI
+$3.36M
2
BIS icon
ProShares UltraShort NASDAQ Biotechnology
BIS
+$2.87M
3
TWM icon
ProShares UltraShort Russell2000
TWM
+$1.9M
4
AEGR
Aegerion Pharmaceuticals
AEGR
+$534K
5
ARIA
Ariad Pharmaceuticals Inc
ARIA
+$385K

Sector Composition

Rank Sector Weight
1 Healthcare 76.73%
2 Miscellaneous 23.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALIM
26
DELISTED
Alimera Sciences
ALIM
$221K 0.32%
6,667
– –
STML
27
DELISTED
Stemline Therapeutics, Inc.
STML
$221K 0.32%
25,000
– –
SEEL
28
CALL
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
0
– –
BIS icon
29
CALL
ProShares UltraShort NASDAQ Biotechnology
BIS
$1.77M
– –
-37,500
Closed -$8.62M
BIS icon
30
ProShares UltraShort NASDAQ Biotechnology
BIS
$1.77M
– –
-12,500
Closed -$2.87M
SUPN icon
31
CALL
Supernus Pharmaceuticals
SUPN
$2.57B
– –
-50,000
Closed -$849K
VIXY icon
32
CALL
ProShares VIX Short-Term Futures ETF
VIXY
$212M
– –
-63
Closed -$1.34M
XOMA
33
CALL
DELISTED
Xoma
XOMA
– –
-3,500
Closed -$272K
VIRX
34
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
-952
Closed -$343K
1
2

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q3 2015 Portfolio in Review

As of Q3 2015, Healthcare Value Capital held 34 positions worth $70.1M, down 26% from $95.2M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Healthcare Value Capital's Q3 2015 filing shows 3 new, 3 increased, 8 reduced and 6 closed positions. The largest sale was Albany Molecular Research Inc, an estimated $3.36M.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, up from 66% a quarter earlier, followed by Miscellaneous.

  • Healthcare Value Capital added most to ANI Pharmaceuticals in Q3 2015, an estimated $10.8M increase.
  • Healthcare Value Capital's biggest Q3 2015 reduction was Albany Molecular Research Inc, cutting an estimated $3.36M.
  • Healthcare Value Capital fully exited ProShares UltraShort NASDAQ Biotechnology in Q3 2015, selling an estimated $2.87M.
  • Healthcare Value Capital's ten largest holdings make up 78% of its $70.1M portfolio in Q3 2015.
  • Healthcare Value Capital opened 3 new positions and closed 6 in Q3 2015.
  • Healthcare Value Capital's portfolio value fell 26% quarter-over-quarter to $70.1M.

Based on Healthcare Value Capital's 13F filing for Q3 2015, filed 16 Nov 2015.